NEW YORK--Blackstone (NYSE: BX) today announced that Blackstone Real Estate Partners VIII L.P. and co-investors have agreed to sell BioMed Realty for $14.6 billion to a group led by existing BioMed investors. This is part of a new long-term, perpetual capital, core+ return strategy managed by Blackstone. BioMed is the largest private owner of life science […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Seattle's most storied piece of Westlake Avenue real estate is headed toward...
ByThe RegistrySeptember 25, 2026Construction has begun on replacement stations in Monroe and Lake Stevens roughly...
ByThe RegistrySeptember 25, 2026A San Francisco-born fast casual chicken concept is following a proven multi-unit...
ByThe RegistrySeptember 25, 2026Wells Fargo's September economic outlook points to a widening split in Pacific...
ByThe RegistrySeptember 25, 2026